Loading…
Overexpression of miR-17 is correlated with liver metastasis in colorectal cancer
Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in men and women. The presence of systemic disease, with metastatic spread to distant sites such as the liver, considerably reduces the survival rate in CRC. Cancer stem cells contribute to the metastatic potential of CRC....
Saved in:
Published in: | Medicine (Baltimore) 2020-02, Vol.99 (9), p.e19265-e19265 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c455t-c6fff6e8eaf051261d8a906a7b89f5cb939865c1f9caba71c013a0d6104bf1413 |
---|---|
cites | cdi_FETCH-LOGICAL-c455t-c6fff6e8eaf051261d8a906a7b89f5cb939865c1f9caba71c013a0d6104bf1413 |
container_end_page | e19265 |
container_issue | 9 |
container_start_page | e19265 |
container_title | Medicine (Baltimore) |
container_volume | 99 |
creator | Lai, Hao Zhang, Jie Zuo, Hongqun Liu, Haizhou Xu, Jing Feng, Yan Lin, Yuan Mo, Xianwei |
description | Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in men and women. The presence of systemic disease, with metastatic spread to distant sites such as the liver, considerably reduces the survival rate in CRC. Cancer stem cells contribute to the metastatic potential of CRC. However, the mechanism underlying metastasis in CRC remains unclear. Thus, this study aimed to examine the expression of microRNAs (miRNAs) in CRC stem cells in cases of liver metastases and assess their correlation with clinicopathological features.
miRNAs showing high expression in liver metastases and primary lesions were selected through data mining of gene expression omnibus datasets, and miRNAs characteristic of stem cells were selected through COREMINE medical text mining. Subsequently, paired formalin-fixed paraffin-embedded tissue samples of primary CRC and liver metastasis from 30 patients were examined for the expression of miRNAs common to these lists (hsa-miR-20a, hsa-miR-26b, hsa-miR-146a, hsa-miR-17, hsa-miR-451, hsa-miR-23a, and hsa-miR-29a) using quantitative real-time polymerase chain reaction. Further, miRNA expression was compared between liver metastases and the primary tumor in each patient and the factors associated with differential expression were analyzed.
hsa-miR-17 was significantly upregulated in liver metastases (P |
doi_str_mv | 10.1097/MD.0000000000019265 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7478658</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2369893208</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-c6fff6e8eaf051261d8a906a7b89f5cb939865c1f9caba71c013a0d6104bf1413</originalsourceid><addsrcrecordid>eNpdkU1LxDAQhoMouq7-AkF69NI1aZqkuQji-gWKKHoOaTrRSNusSXfVf29k189hYA7zzDsvMwjtETwhWIrD6-kE_wSRBWdraEQY5TmTvFxHI4wLlgspyi20HeNzgqgoyk20RQtCKkHLEbq9WUCAt1mAGJ3vM2-zzt3lRGQuZsaHAK0eoMle3fCUtS7BWQeDjikT4PrEtD6AGXSbGd0bCDtow-o2wu6qjtHD2en9yUV-dXN-eXJ8lZuSsSE33FrLoQJtMSMFJ02lJeZa1JW0zNSSyoozQ6w0utaCmGRe44YTXNaWlISO0dFSdzavO2gM9EPQrZoF1-nwrrx26m-nd0_q0S-UKEVSrpLAwUog-Jc5xEF1LhpoW92Dn0dVUC4rSQv8idIlaoKPMYD9XkOw-nyGup6q_89IU_u_HX7PfF2ffgBjnYZw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2369893208</pqid></control><display><type>article</type><title>Overexpression of miR-17 is correlated with liver metastasis in colorectal cancer</title><source>LWW_医学期刊</source><source>IngentaConnect Journals</source><source>PubMed Central</source><creator>Lai, Hao ; Zhang, Jie ; Zuo, Hongqun ; Liu, Haizhou ; Xu, Jing ; Feng, Yan ; Lin, Yuan ; Mo, Xianwei</creator><creatorcontrib>Lai, Hao ; Zhang, Jie ; Zuo, Hongqun ; Liu, Haizhou ; Xu, Jing ; Feng, Yan ; Lin, Yuan ; Mo, Xianwei</creatorcontrib><description>Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in men and women. The presence of systemic disease, with metastatic spread to distant sites such as the liver, considerably reduces the survival rate in CRC. Cancer stem cells contribute to the metastatic potential of CRC. However, the mechanism underlying metastasis in CRC remains unclear. Thus, this study aimed to examine the expression of microRNAs (miRNAs) in CRC stem cells in cases of liver metastases and assess their correlation with clinicopathological features.
miRNAs showing high expression in liver metastases and primary lesions were selected through data mining of gene expression omnibus datasets, and miRNAs characteristic of stem cells were selected through COREMINE medical text mining. Subsequently, paired formalin-fixed paraffin-embedded tissue samples of primary CRC and liver metastasis from 30 patients were examined for the expression of miRNAs common to these lists (hsa-miR-20a, hsa-miR-26b, hsa-miR-146a, hsa-miR-17, hsa-miR-451, hsa-miR-23a, and hsa-miR-29a) using quantitative real-time polymerase chain reaction. Further, miRNA expression was compared between liver metastases and the primary tumor in each patient and the factors associated with differential expression were analyzed.
hsa-miR-17 was significantly upregulated in liver metastases (P < .05), but no significant difference in the expression of hsa-miR-26b, hsa-miR-146a, hsa-miR-451, hsa-miR-23a, and hsa-miR-29a was observed between primary tumors and liver metastases. The higher expression of hsa-miR-17 in liver metastases was associated with the administration of neoadjuvant chemotherapy and tumor differentiation (P < .05) but was not associated with age, sex, tumor location, or lymphatic metastasis.
High expression of miR-17 may contribute to liver metastasis in CRC. Therefore, an in-depth understanding of its downstream pathways could help in elucidating the mechanisms underlying liver metastases in CRC. However, additional studies are warranted to validate these findings.</description><identifier>ISSN: 0025-7974</identifier><identifier>EISSN: 1536-5964</identifier><identifier>DOI: 10.1097/MD.0000000000019265</identifier><identifier>PMID: 32118734</identifier><language>eng</language><publisher>United States: Wolters Kluwer Health</publisher><subject>Clinical Trial/Experimental Study ; Colorectal Neoplasms - blood ; Colorectal Neoplasms - pathology ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Liver Neoplasms - blood ; Liver Neoplasms - secondary ; Male ; MicroRNAs - blood ; MicroRNAs - metabolism ; Middle Aged ; Neoplasm Metastasis ; Polymerase Chain Reaction</subject><ispartof>Medicine (Baltimore), 2020-02, Vol.99 (9), p.e19265-e19265</ispartof><rights>Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-c6fff6e8eaf051261d8a906a7b89f5cb939865c1f9caba71c013a0d6104bf1413</citedby><cites>FETCH-LOGICAL-c455t-c6fff6e8eaf051261d8a906a7b89f5cb939865c1f9caba71c013a0d6104bf1413</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478658/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478658/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32118734$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lai, Hao</creatorcontrib><creatorcontrib>Zhang, Jie</creatorcontrib><creatorcontrib>Zuo, Hongqun</creatorcontrib><creatorcontrib>Liu, Haizhou</creatorcontrib><creatorcontrib>Xu, Jing</creatorcontrib><creatorcontrib>Feng, Yan</creatorcontrib><creatorcontrib>Lin, Yuan</creatorcontrib><creatorcontrib>Mo, Xianwei</creatorcontrib><title>Overexpression of miR-17 is correlated with liver metastasis in colorectal cancer</title><title>Medicine (Baltimore)</title><addtitle>Medicine (Baltimore)</addtitle><description>Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in men and women. The presence of systemic disease, with metastatic spread to distant sites such as the liver, considerably reduces the survival rate in CRC. Cancer stem cells contribute to the metastatic potential of CRC. However, the mechanism underlying metastasis in CRC remains unclear. Thus, this study aimed to examine the expression of microRNAs (miRNAs) in CRC stem cells in cases of liver metastases and assess their correlation with clinicopathological features.
miRNAs showing high expression in liver metastases and primary lesions were selected through data mining of gene expression omnibus datasets, and miRNAs characteristic of stem cells were selected through COREMINE medical text mining. Subsequently, paired formalin-fixed paraffin-embedded tissue samples of primary CRC and liver metastasis from 30 patients were examined for the expression of miRNAs common to these lists (hsa-miR-20a, hsa-miR-26b, hsa-miR-146a, hsa-miR-17, hsa-miR-451, hsa-miR-23a, and hsa-miR-29a) using quantitative real-time polymerase chain reaction. Further, miRNA expression was compared between liver metastases and the primary tumor in each patient and the factors associated with differential expression were analyzed.
hsa-miR-17 was significantly upregulated in liver metastases (P < .05), but no significant difference in the expression of hsa-miR-26b, hsa-miR-146a, hsa-miR-451, hsa-miR-23a, and hsa-miR-29a was observed between primary tumors and liver metastases. The higher expression of hsa-miR-17 in liver metastases was associated with the administration of neoadjuvant chemotherapy and tumor differentiation (P < .05) but was not associated with age, sex, tumor location, or lymphatic metastasis.
High expression of miR-17 may contribute to liver metastasis in CRC. Therefore, an in-depth understanding of its downstream pathways could help in elucidating the mechanisms underlying liver metastases in CRC. However, additional studies are warranted to validate these findings.</description><subject>Clinical Trial/Experimental Study</subject><subject>Colorectal Neoplasms - blood</subject><subject>Colorectal Neoplasms - pathology</subject><subject>Female</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Humans</subject><subject>Liver Neoplasms - blood</subject><subject>Liver Neoplasms - secondary</subject><subject>Male</subject><subject>MicroRNAs - blood</subject><subject>MicroRNAs - metabolism</subject><subject>Middle Aged</subject><subject>Neoplasm Metastasis</subject><subject>Polymerase Chain Reaction</subject><issn>0025-7974</issn><issn>1536-5964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpdkU1LxDAQhoMouq7-AkF69NI1aZqkuQji-gWKKHoOaTrRSNusSXfVf29k189hYA7zzDsvMwjtETwhWIrD6-kE_wSRBWdraEQY5TmTvFxHI4wLlgspyi20HeNzgqgoyk20RQtCKkHLEbq9WUCAt1mAGJ3vM2-zzt3lRGQuZsaHAK0eoMle3fCUtS7BWQeDjikT4PrEtD6AGXSbGd0bCDtow-o2wu6qjtHD2en9yUV-dXN-eXJ8lZuSsSE33FrLoQJtMSMFJ02lJeZa1JW0zNSSyoozQ6w0utaCmGRe44YTXNaWlISO0dFSdzavO2gM9EPQrZoF1-nwrrx26m-nd0_q0S-UKEVSrpLAwUog-Jc5xEF1LhpoW92Dn0dVUC4rSQv8idIlaoKPMYD9XkOw-nyGup6q_89IU_u_HX7PfF2ffgBjnYZw</recordid><startdate>20200201</startdate><enddate>20200201</enddate><creator>Lai, Hao</creator><creator>Zhang, Jie</creator><creator>Zuo, Hongqun</creator><creator>Liu, Haizhou</creator><creator>Xu, Jing</creator><creator>Feng, Yan</creator><creator>Lin, Yuan</creator><creator>Mo, Xianwei</creator><general>Wolters Kluwer Health</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200201</creationdate><title>Overexpression of miR-17 is correlated with liver metastasis in colorectal cancer</title><author>Lai, Hao ; Zhang, Jie ; Zuo, Hongqun ; Liu, Haizhou ; Xu, Jing ; Feng, Yan ; Lin, Yuan ; Mo, Xianwei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-c6fff6e8eaf051261d8a906a7b89f5cb939865c1f9caba71c013a0d6104bf1413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Clinical Trial/Experimental Study</topic><topic>Colorectal Neoplasms - blood</topic><topic>Colorectal Neoplasms - pathology</topic><topic>Female</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Humans</topic><topic>Liver Neoplasms - blood</topic><topic>Liver Neoplasms - secondary</topic><topic>Male</topic><topic>MicroRNAs - blood</topic><topic>MicroRNAs - metabolism</topic><topic>Middle Aged</topic><topic>Neoplasm Metastasis</topic><topic>Polymerase Chain Reaction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lai, Hao</creatorcontrib><creatorcontrib>Zhang, Jie</creatorcontrib><creatorcontrib>Zuo, Hongqun</creatorcontrib><creatorcontrib>Liu, Haizhou</creatorcontrib><creatorcontrib>Xu, Jing</creatorcontrib><creatorcontrib>Feng, Yan</creatorcontrib><creatorcontrib>Lin, Yuan</creatorcontrib><creatorcontrib>Mo, Xianwei</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lai, Hao</au><au>Zhang, Jie</au><au>Zuo, Hongqun</au><au>Liu, Haizhou</au><au>Xu, Jing</au><au>Feng, Yan</au><au>Lin, Yuan</au><au>Mo, Xianwei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Overexpression of miR-17 is correlated with liver metastasis in colorectal cancer</atitle><jtitle>Medicine (Baltimore)</jtitle><addtitle>Medicine (Baltimore)</addtitle><date>2020-02-01</date><risdate>2020</risdate><volume>99</volume><issue>9</issue><spage>e19265</spage><epage>e19265</epage><pages>e19265-e19265</pages><issn>0025-7974</issn><eissn>1536-5964</eissn><abstract>Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in men and women. The presence of systemic disease, with metastatic spread to distant sites such as the liver, considerably reduces the survival rate in CRC. Cancer stem cells contribute to the metastatic potential of CRC. However, the mechanism underlying metastasis in CRC remains unclear. Thus, this study aimed to examine the expression of microRNAs (miRNAs) in CRC stem cells in cases of liver metastases and assess their correlation with clinicopathological features.
miRNAs showing high expression in liver metastases and primary lesions were selected through data mining of gene expression omnibus datasets, and miRNAs characteristic of stem cells were selected through COREMINE medical text mining. Subsequently, paired formalin-fixed paraffin-embedded tissue samples of primary CRC and liver metastasis from 30 patients were examined for the expression of miRNAs common to these lists (hsa-miR-20a, hsa-miR-26b, hsa-miR-146a, hsa-miR-17, hsa-miR-451, hsa-miR-23a, and hsa-miR-29a) using quantitative real-time polymerase chain reaction. Further, miRNA expression was compared between liver metastases and the primary tumor in each patient and the factors associated with differential expression were analyzed.
hsa-miR-17 was significantly upregulated in liver metastases (P < .05), but no significant difference in the expression of hsa-miR-26b, hsa-miR-146a, hsa-miR-451, hsa-miR-23a, and hsa-miR-29a was observed between primary tumors and liver metastases. The higher expression of hsa-miR-17 in liver metastases was associated with the administration of neoadjuvant chemotherapy and tumor differentiation (P < .05) but was not associated with age, sex, tumor location, or lymphatic metastasis.
High expression of miR-17 may contribute to liver metastasis in CRC. Therefore, an in-depth understanding of its downstream pathways could help in elucidating the mechanisms underlying liver metastases in CRC. However, additional studies are warranted to validate these findings.</abstract><cop>United States</cop><pub>Wolters Kluwer Health</pub><pmid>32118734</pmid><doi>10.1097/MD.0000000000019265</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0025-7974 |
ispartof | Medicine (Baltimore), 2020-02, Vol.99 (9), p.e19265-e19265 |
issn | 0025-7974 1536-5964 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7478658 |
source | LWW_医学期刊; IngentaConnect Journals; PubMed Central |
subjects | Clinical Trial/Experimental Study Colorectal Neoplasms - blood Colorectal Neoplasms - pathology Female Gene Expression Regulation, Neoplastic Humans Liver Neoplasms - blood Liver Neoplasms - secondary Male MicroRNAs - blood MicroRNAs - metabolism Middle Aged Neoplasm Metastasis Polymerase Chain Reaction |
title | Overexpression of miR-17 is correlated with liver metastasis in colorectal cancer |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T10%3A31%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Overexpression%20of%20miR-17%20is%20correlated%20with%20liver%20metastasis%20in%20colorectal%20cancer&rft.jtitle=Medicine%20(Baltimore)&rft.au=Lai,%20Hao&rft.date=2020-02-01&rft.volume=99&rft.issue=9&rft.spage=e19265&rft.epage=e19265&rft.pages=e19265-e19265&rft.issn=0025-7974&rft.eissn=1536-5964&rft_id=info:doi/10.1097/MD.0000000000019265&rft_dat=%3Cproquest_pubme%3E2369893208%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c455t-c6fff6e8eaf051261d8a906a7b89f5cb939865c1f9caba71c013a0d6104bf1413%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2369893208&rft_id=info:pmid/32118734&rfr_iscdi=true |